Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mehrdad Shakib-Azar
Observed name:
M. Shakib Azar
Institution:
Fred Hutch Cancer Center
Observed institution:
Fred Hutch Cancer Center
OpenAlex ID:
A5093396512
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma
2025
·
Laura Samples
, Hossein Sadrzadeh
, et al.
·
Blood
·
17
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study
2024
·
Laura Samples
, Jenna Voutsinas
, et al.
·
Blood Advances
·
13
PDF
Clinical Outcomes in Patients Treated with Both Covalent Btkis and Venetoclax and the Significance of “Double-Refractory” Status in Patients with CLL/SLL
2023
·
Laura Samples
, Chaitra S Ujjani
, et al.
·
Blood
·
12
Predictors of Outcomes with Venetoclax-Based Treatment in Patients with Progressive Disease or Intolerance after Covalent BTK Inhibitors
2023
·
Laura Samples
, Sirin Khajaviyan
, et al.
·
Blood
·
1
P675: Treatment of Hypertension in Patients Receiving Btk Inhibitors: a Multicenter Retrospective Study
2022
·
M. Shadman
, J. Voutsinas
, et al.
·
HemaSphere
·
1
Real-World Blood Counts in Patients Treated with Venetoclax for Relapsed or Refractory CLL/SLL
2024
·
Laura Samples
, Sirin Khajaviyan
, et al.
·
Blood
Acalabrutinib and Venetoclax (AV) Combination for 2 Years for Patients with Previously Treated CLL/SLL - the Avenue-2 Trial
2024
·
Jennifer J. Huang
, Laura Samples
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
7
Citation count:
44
H-index:
3
I10-index:
3
Year
Topic
Type
